Danaher Corporation $DHR Stake Cut by RWA Wealth Partners LLC

Key Points

• RWA Wealth Partners LLC reduced its stake in Danaher Corporation by 49.9% in Q1, now owning 6,445 shares valued at approximately $1.32 million.
• Significant changes in institutional ownership were observed, with Nuveen LLC investing $833.94 million and GAMMA Investing LLC increasing its position by an astounding 24,958.2%.
• Analysts have given Danaher a consensus rating of "Moderate Buy" with a target price around $247.61, while recent earnings reports surpassed expectations with $1.80 EPS against a $1.64 forecast.

RWA Wealth Partners LLC cut its position in shares of Danaher Corporation (NYSE:DHR - Free Report) by 49.9% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,445 shares of the conglomerate's stock after selling 6,411 shares during the quarter. RWA Wealth Partners LLC's holdings in Danaher were worth $1,321,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in DHR. Nuveen LLC bought a new position in Danaher during the first quarter worth $833,941,000. GAMMA Investing LLC increased its position in Danaher by 24,958.2% in the first quarter. GAMMA Investing LLC now owns 1,870,847 shares of the conglomerate's stock worth $383,524,000 after buying an additional 1,863,381 shares during the period. Two Sigma Advisers LP increased its position in Danaher by 4,248.8% in the fourth quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate's stock worth $376,347,000 after buying an additional 1,601,800 shares during the period. Invesco Ltd. increased its position in Danaher by 44.5% in the first quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate's stock worth $965,259,000 after buying an additional 1,450,703 shares during the period. Finally, Point72 Asset Management L.P. increased its position in Danaher by 460.6% in the fourth quarter. Point72 Asset Management L.P. now owns 1,348,544 shares of the conglomerate's stock worth $309,558,000 after buying an additional 1,107,998 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

DHR has been the topic of several analyst reports. TD Cowen increased their target price on Danaher from $240.00 to $248.00 and gave the stock a "buy" rating in a research report on Wednesday, April 23rd. JPMorgan Chase & Co. dropped their target price on Danaher from $280.00 to $260.00 and set an "overweight" rating on the stock in a research report on Tuesday, April 22nd. Argus dropped their target price on Danaher from $260.00 to $240.00 in a research report on Wednesday, April 23rd. Deutsche Bank Aktiengesellschaft dropped their target price on Danaher from $240.00 to $235.00 in a research report on Thursday, June 5th. Finally, Jefferies Financial Group dropped their target price on Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a research report on Tuesday, April 22nd. Seventeen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, Danaher has a consensus rating of "Moderate Buy" and a consensus target price of $247.61.

Danaher Price Performance

Shares of DHR opened at $212.2350 on Wednesday. The firm has a market capitalization of $151.97 billion, a price-to-earnings ratio of 45.16, a price-to-earnings-growth ratio of 2.92 and a beta of 0.73. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. Danaher Corporation has a one year low of $171.00 and a one year high of $279.90. The stock's fifty day moving average is $200.33 and its 200-day moving average is $199.54.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. The company had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company's quarterly revenue was up 3.4% compared to the same quarter last year. During the same period last year, the company earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.